Viking Therapeutics (1VT)
DB • 1VT • US92686J1060
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 7% of free float sold short, 12,787.7 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Market Cap
3.42b USD | # 3079 in DE
Volume
530 shares | 52.73k USD
Shares Outstanding
127.52m
Free Float Shares
97.71% | 124.6m
